KaloBios (KBIO) is now in Oversold Territory
moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios is hiring next, click here to view […]
KBIO
KaloBios reports Q1 EPS (32c), consensus (38c)
moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios is hiring next, click here to view […]
KALOBIOS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios is hiring next, click here to view […]
KaloBios Provides First Quarter 2014 Financial Results
[PR Newswire] – SOUTH SAN FRANCISCO, Calif., May 8, 2014 /PRNewswire/ — KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced financial results for the first quarter of 2014 and provided an update on its current … moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios is hiring next, click here to […]
Ted W. Love, M.D., Named Chairman of the Board of KaloBios
[PR Newswire] – SOUTH SAN FRANCISCO, May 6, 2014 /PRNewswire/ — KaloBios Pharmaceuticals, Inc. (KBIO) today announced that the company’s board of directors has elected Ted W. Love, M.D., as the Chairman, effective May 1, 2014. Dr. Love succeeds James I. moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios […]
KALOBIOS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios is hiring next, click here to view […]
KaloBios Announces Upcoming Participation at Needham Healthcare Conference
[PR Newswire] – SOUTH SAN FRANCISCO, Calif., April 3, 2014 /PRNewswire/ — KaloBios Pharmaceuticals, Inc. (KBIO) today announced that the company will be presenting at the following upcoming investor conference: Presentations will include overviews of th moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios is hiring next, click here […]
How KaloBios (KBIO) Stock Stands Out in a Strong Industry
moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios is hiring next, click here to view […]
KaloBios Initiates Phase 2 Expansion Portion of Study of KB004 in Hematologic Malignancies
[PR Newswire] – SOUTH SAN FRANCISCO, Calif., Feb. 11, 2014 /PRNewswire/ — KaloBios Pharmaceuticals, Inc. (KBIO) today announced that the company has begun treating patients in the Phase 2 expansion portion of study KB004-01 evaluating KB004, the company moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios is hiring next, […]
KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
[at noodls] – SOUTH SAN FRANCISCO, CA (January 31, 2013): KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) today announced the pricing of its previously announced initial public offering of 8,750,000 shares of common stock … moreView todays social media effects on KBIOView the latest stocks trending across Twitter. Click to view dashboardSee who KaloBios is hiring next, click here to view […]
